CytoDyn Inc. (OTCMKTS:CYDY) Short Interest Update

CytoDyn Inc. (OTCMKTS:CYDY) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 20,123,400 shares, an increase of 15.0% from the December 15th total of 17,499,100 shares. Based on an average daily volume of 6,176,200 shares, the days-to-cover ratio is presently 3.3 days.

CytoDyn Stock Performance

Shares of OTCMKTS CYDY traded up $0.00 during midday trading on Friday, reaching $0.15. 1,217,001 shares of the stock were exchanged, compared to its average volume of 2,325,929. The stock has a 50 day moving average price of $0.12 and a 200-day moving average price of $0.14. CytoDyn has a 52-week low of $0.10 and a 52-week high of $0.32.

CytoDyn Company Profile

CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.